Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Panic disorder.

Peter P Roy-Byrne1, Michelle G Craske, Murray B Stein

  • 1Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine at Harborview Medical Center, Seattle, WA 98104-2499, USA. roybyrne@u.washington.edu

Lancet (London, England)
|September 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Positive and negative affect influence learning during exposure therapy: Secondary analysis from a randomized controlled trial.

Journal of anxiety disorders·2026
Same author

Expectancy updating predicts anxiety symptom reduction from exposure therapy: Predictive analyses from a randomized clinical trial.

Behaviour research and therapy·2026
Same author

Positive Affect Treatment for Depression, Anxiety, and Low Positive Affect: A Randomized Clinical Trial.

JAMA network open·2026
Same author

Peer Mentor Training and Supervision for a Digital Adolescent Depression Treatment in South Africa and Uganda: Mixed Methods Evaluation.

JMIR mental health·2026
Same author

Testing a hierarchical model of neuroticism and its cognitive facets: Latent structure and prospective prediction of first onsets of anxiety and unipolar mood disorders during 3 years in late adolescence.

Clinical psychological science : a journal of the Association for Psychological Science·2026
Same author

New and emerging treatments for anxiety disorders.

BMJ (Clinical research ed.)·2026
Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026
Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
See all related articles

Panic disorder affects 5% of people, causing disability and reduced quality of life. Effective treatments like cognitive-behavioral therapy are available and should be widely disseminated.

Area of Science:

  • Psychiatry
  • Mental Health
  • Public Health

Background:

  • Panic disorder affects up to 5% of the population, leading to significant disability and reduced quality of life.
  • Complications like agoraphobia exacerbate functional morbidity and societal costs, including healthcare utilization and lost productivity.
  • While physical illnesses and lifestyle factors are associated with panic disorder, causal pathways remain unclear, as do the roles of genetic and early experiential factors.

Purpose of the Study:

  • To review the prevalence, impact, and treatment of panic disorder.
  • To highlight the need for effective dissemination of evidence-based treatments.

Main Methods:

  • Literature review of panic disorder prevalence, associated factors, and treatment efficacy.
  • Synthesis of evidence regarding pharmacological and cognitive-behavioral therapies.

Related Experiment Videos

Main Results:

  • Panic disorder is a common and disabling condition with significant economic and social costs.
  • Effective treatments, including pharmacological and cognitive-behavioral approaches, are supported by strong evidence.
  • Understanding of causal pathways, including genetic and environmental factors, is still developing.

Conclusions:

  • Despite incomplete knowledge of causes, effective treatments for panic disorder exist.
  • Urgent public health goals should focus on adapting and disseminating these treatments into mainstream medical care.